| Authors: |
Balaraman S; Department of Neuroscience and Experimental Therapeutics, Texas A&M Health Science Center, College of Medicine, Bryan, Texas, United States of America., Schafer JJ; Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America., Tseng AM; Department of Neuroscience and Experimental Therapeutics, Texas A&M Health Science Center, College of Medicine, Bryan, Texas, United States of America., Wertelecki W; Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America.; Omni-Net Ukraine Birth Defects Prevention Program, Rivne, Ukraine.; The Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), San Diego, California, United States of America., Yevtushok L; Omni-Net Ukraine Birth Defects Prevention Program, Rivne, Ukraine.; Rivne Provincial Medical Diagnostic Center and OMNI-Net Center, Rivne, Ukraine.; The Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), San Diego, California, United States of America., Zymak-Zakutnya N; Omni-Net Ukraine Birth Defects Prevention Program, Rivne, Ukraine.; Khmelnytsky City Perinatal Center and OMNI-Net Center, Khmelnytsky, Ukraine.; The Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), San Diego, California, United States of America., Chambers CD; Department of Pediatrics, University of California San Diego, La Jolla, California, United States of America.; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, United States of America.; The Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), San Diego, California, United States of America., Miranda RC; Department of Neuroscience and Experimental Therapeutics, Texas A&M Health Science Center, College of Medicine, Bryan, Texas, United States of America.; The Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), San Diego, California, United States of America. |
